Oncovision launches the new Mammi software 2.2

Successfully installed and tested at Mayo Clinic, Ruber International and University of California, San Francisco (UCSF), Mammi software 2.2 features new and innovative tools that optimize the performance of Mammi equipment. Mammi software 2.2 also facilitates workflow to provide the most accurate and efficient breast cancer diagnosis possible.

Mammi is a dedicated breast PET that uses an exclusive continuous crystal, ring design and high-resolution images (down to 1.6 mm) to allow the visualization of very small tumors. The amazing imaging abilities of Mammi make it an essential tool in early-stage breast cancer detection.

Wholly development and implemented by Oncovision, Mammi software 2.2 has earned CE and FDA certification. and reflects Oncovision’s new brand image.

This new software version is 100% compatible with DICOM images and picture archiving and communication system (PACS) already in use. Mammi software 2.2 connects immediately with the main hospital database to make workflow much easier and more efficient.

Mammi software complies with the HIPAA regulation (Health Insurance Portability and Accountability Act), improving security and ensuring the confidentiality between patient and hospital.

Leading medical centers, such as Mayo Clinic, UCSF, and Ruber International Hospital in Madrid, Spain, have already upgraded their Mammi devices to Mammi software 2.2 as a way to ensure accurate interpretation of breast molecular images.